Ghobrial IM - Search Results

1

A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.

Witzig TE, Reeder CB, LaPlant BR, Gupta M, Johnston PB, Micallef IN, Porrata LF, Ansell SM, Colgan JP, Jacobsen ED, Ghobrial IM, Habermann TM. Witzig TE, et al. Among authors: ghobrial im. Leukemia. 2011 Feb;25(2):341-7. doi: 10.1038/leu.2010.226. Epub 2010 Dec 7. Leukemia. 2011. PMID: 21135857 Free PMC article. Clinical Trial.

2

Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma.

Ghobrial IM, Dispenzieri A, Bundy KL, Gastineau DA, Rajkumar SV, Therneau TM, Lacy MQ, Witzig TE, Litzow MR, Christensen BR, Hayman S, Pribula CG, Gertz MA. Ghobrial IM, et al. Bone Marrow Transplant. 2003 Sep;32(6):587-92. doi: 10.1038/sj.bmt.1704173. Bone Marrow Transplant. 2003. PMID: 12953131

3

Therapeutic options in patients with lymphoma and severe liver dysfunction.

Ghobrial IM, Wolf RC, Pereira DL, Fonseca R, White WL, Colgan JP, Habermann TM, Inwards DJ, Markovic SN, Ansell SM, Micallef IN, Porrata LF, Witzig TE. Ghobrial IM, et al. Mayo Clin Proc. 2004 Feb;79(2):169-75. doi: 10.4065/79.2.169. Mayo Clin Proc. 2004. PMID: 14959910

4

Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.

Ghobrial IM, Bone ND, Stenson MJ, Novak A, Hedin KE, Kay NE, Ansell SM. Ghobrial IM, et al. Mayo Clin Proc. 2004 Mar;79(3):318-25. doi: 10.4065/79.3.318. Mayo Clin Proc. 2004. PMID: 15008605

5

Waldenström macroglobulinemia.

Ghobrial IM, Witzig TE. Ghobrial IM, et al. Curr Treat Options Oncol. 2004 Jun;5(3):239-47. doi: 10.1007/s11864-004-0015-5. Curr Treat Options Oncol. 2004. PMID: 15115652 Free PMC article. Review.

6

High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis.

Ghobrial IM, Buadi F, Spinner RJ, Colgan JP, Wolanskyj AP, Dyck PJ, Witzig TE, Micallef IN, O'Neill BP. Ghobrial IM, et al. Cancer. 2004 Jun 1;100(11):2403-7. doi: 10.1002/cncr.20263. Cancer. 2004. PMID: 15160344 Free article.

7

Radioimmunotherapy: a new treatment modality for B-cell non-Hodgkin's lymphoma.

Ghobrial I, Witzig T. Ghobrial I, et al. Oncology (Williston Park). 2004 May;18(5):623-30; discussion 633-4, 637-8, 640. Oncology (Williston Park). 2004. PMID: 15209190 Review.

8

Initial increase in the cryoglobulin level after rituximab therapy for type II cryoglobulinemia secondary to Waldenström macroglobulinemia does not indicate failure of response.

Ghobrial IM, Uslan DZ, Call TG, Witzig TE, Gertz MA. Ghobrial IM, et al. Am J Hematol. 2004 Dec;77(4):329-30. doi: 10.1002/ajh.20207. Am J Hematol. 2004. PMID: 15551276 Free article.

9

Prognostic factors in patients with post-transplant lymphoproliferative disorders (PTLD) in the rituximab era.

Ghobrial IM, Habermann TM, Ristow KM, Ansell SM, Macon W, Geyer SM, McGregor CG. Ghobrial IM, et al. Leuk Lymphoma. 2005 Feb;46(2):191-6. doi: 10.1080/10428190400012011. Leuk Lymphoma. 2005. PMID: 15621801 Clinical Trial.

10

Proteomic analysis of mantle-cell lymphoma by protein microarray.

Ghobrial IM, McCormick DJ, Kaufmann SH, Leontovich AA, Loegering DA, Dai NT, Krajnik KL, Stenson MJ, Melhem MF, Novak AJ, Ansell SM, Witzig TE. Ghobrial IM, et al. Blood. 2005 May 1;105(9):3722-30. doi: 10.1182/blood-2004-10-3999. Epub 2005 Jan 13. Blood. 2005. PMID: 15650054 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

374 results

Search Page

Filters